INFU (InfuSystem Holdings) יחס שווי שוק לשווי בספרים

The price action of InfuSystem Holdings (INFU) securities reflects the dynamics of a company with a metric of 4.68. The business has established a closed ecosystem for infusion therapy by integrating software and equipment, making it nearly impossible for hospitals to switch to other providers. Revenues are based on long-term leases of chemotherapy pumps, creating a stable cash flow. This stability is supported by a strong staff of technicians and the active hiring of sales representatives.

To build a defensive portfolio, fundamental screening relies on comparing the market price of shares with the net asset value, which allows for the identification of business overvaluation relative to its actual capital. Amid logistics disruptions and export sanctions on medical technology affecting InfuSystem Holdings (INFU), the history of the market value significantly exceeding the book value clearly demonstrates how external shocks impact the company's investment attractiveness and resilience.